Top Story

FDA grants priority review for expanded use of Kyprolis in relapsed multiple myeloma

March 30, 2015

The FDA today accepted the supplemental new drug application of carfilzomib for the treatment of patients with relapsed multiple myeloma who have received at least one prior therapy, according to a press release from the drug’s manufacturer.

In addition, the FDA granted carfilzomib (Kyprolis, Amgen) priority review with a Prescription Drug User Fee Act target action date of July 26, 2015.

Dennis Slamon Industry News

Panel of cancer experts highlight advancements in precision medicine

March 30, 2015
Advancements in the understanding of cancer genetics have led to important breakthroughs in precision medicine, according to a Columbia University media briefing on the…

Experts discuss whether shift in Medicare will reduce costs, improve quality of care

March 30, 2015
In response to concerns over Medicare’s current fee-for-service payment system, the Obama administration announced in January that by 2018 Medicare instead will…

Tumor profiling model finds potential therapeutic agents for HCC

March 30, 2015
In a retrospective study, researchers used Caris Molecular Intelligence to identify molecular patterns and therapeutic options for hepatocellular carcinoma and presented…
In the Journals

Aprepitant effective for CINV prevention in children

March 30, 2015
The addition of aprepitant to ondansetron effectively reduced or prevented chemotherapy-induced nausea and vomiting in pediatric patients who underwent moderately or…
More News Headlines »
CME CNE
High Risk AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 2 High Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
Meeting News Coverage Video
thumbnail for video 4126759064001

Solid organ transplant recipients at higher risk for skin cancer

March 22, 2015
SAN FRANCISCO – In this video, Sarah Tuttleton Arron, MD, PhD, FAAD, discusses her research on mortality from…
More »
CME CNE
Stem Cell Transplant for AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 3 Stem Cell Transplant for MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
morganatic-roan